01 July 2026 - The scheme of arrangement for the acquisition by Pan African Resources plc has been implemented, with Emmerson Resources set for imminent delisting from the ASX.
01 July 2026 - Clinical-stage immuno-oncology company Imugene has announced an additional complete response, notably in the first Mantle Cell Lymphoma patient, within its Phase 1b study for azer-cel.